GoodRx shares soar after announcing the company’s partnership with Novo Nordisk to slash the cost of Ozempic. GoodRx CEO Wendy Barnes tells Open Interest that the platform allows patients to get the best drug prices at retail pharmacies. (Source: Bloomberg)
www.bloomberg.com
#GoodRx #Expands #Access #Ozempic
Stay informed with free updates Simply sign up to the Oil myFT Digest — delivered directly to your inbox. Oil…
EQT-backed data center operator EdgeConnex Inc has appointed Morgan Stanley to explore financing options for its growing European activities, according…
Europe’s drug regulator backed GSK Plc’s drug to treat severe asthma or a common nasal condition, in the first such…
